Amarin Corporation (AMRN) Stock Price

Amarin Corporation Price

NASDAQ·CLOSED
12.09
​
Market closed

Revenue has compounded at 37.5% per year over the past 19 years to 213.65 M USD. Amarin Corporation's net margin stands at -18.2%, down from 1.3% several years earlier. Analysts set a median price target of 12.24 USD, implying 1.2% above the current price. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.

Amarin Corporation stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Amarin Corporation business model & stock analysis

Amarin Corporation PLC generates revenue primarily through the sale of Vascepa (icosapent ethyl) capsules, approved by the FDA for reducing triglyceride levels in patients with severe hypertriglyceridemia. The company sells Vascepa to wholesalers, regional wholesalers, and specialty pharmacy providers, collectively referred to as distributors, who then resell the product to retail pharmacies for patient and healthcare provider use. The MARINE indication, derived from the MARINE study, is the key approved use driving sales in the cardiovascular health segment. Amarin's commercial strategy centers on the Vascepa segment, focusing on the development and commercialization of this therapeutic. The firm's lead product, Vascepa, is positioned as an adjunct to diet for treating severe hypertriglyceridemia, targeting healthcare providers and patients through a distribution network of wholesalers and specialty pharmacies. This model ensures Vascepa reaches retail pharmacies where it is dispensed to end users.

Frequently asked questions about Amarin Corporation

Analysts currently set an average price target of 12.24 USD for the Amarin Corporation stock (median: 12.24 USD), implying +2.4 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Amarin Corporation stock: 0 recommend buying, 2 holding and 5 selling. For 2026, analysts expect Amarin Corporation to generate revenue of 177.44 M USD and earnings per share of -0.60 USD.

Converted at the current exchange rate, the Amarin Corporation share trades at 10.85 EUR (12.09 USD).

The Amarin Corporation share (AMRN) is listed on 4 stock exchanges, including: NASDAQ (AMRN), Frankfurt (EH3A.F), München (EH3A.MU), Düsseldorf (EH3A.DU).

The expected revenue of Amarin Corporation is 177.44 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Amarin Corporation is -12.43 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Amarin Corporation is currently -20.24. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Amarin Corporation stock.

The price-to-sales ratio (P/S) of Amarin Corporation is currently 1.42. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Amarin Corporation stock.

The Eulerpool Quality Score for Amarin Corporation is 1/10.

The ISIN of Amarin Corporation is US0231114044. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Amarin Corporation is A0NBNG. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Amarin Corporation is AMRN. The ticker symbol is used to trade Amarin Corporation shares on the stock exchange.

Fair ValueTerminal
12.21 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
2.67 M USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Ireland
Currency
USD
Initial public offering
Apr 1, 1993
ISIN
US0231114044
Cusip
023111206
Sedol
2301938
Market capitalization
250.86 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-20.24
P/Ee 2027
-35.22
P/Ee 2028
-27.34
P/Ee 2029
63.63
P/S
P/Se
1.42
EV/EBIT
1.34
P/B Ratio
0.55
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-8.45 %
Last updated Oct 28, 2026, 3:16 PM

Amarin Corporation Peer Group

Amarin Corporation Ticker

DÜSSELDORF · EH3A.DUFRANKFURT · EH3A.FMUNICH · EH3A.MUNASDAQ · AMRN